Title : Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations.

Pub. Date : 2021

PMID : 34659899






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Asciminib and ponatinib also produced cooperative effects on CRKL phosphorylation in BCR-ABL1-transformed cells. asciminib CRK like proto-oncogene, adaptor protein Homo sapiens